Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohamed, F.
Right arrow Articles by Sugarbaker, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohamed, F.
Right arrow Articles by Sugarbaker, P. H.
Journal of Clinical Oncology, Vol 21, Issue 7 (April), 2003: 1419-1420
© 2003 American Society for Clinical Oncology


DIAGNOSIS IN ONCOLOGY

Challenging and Unusual Cases

CASE 3. PERITONEAL CYSTIC MESOTHELIOMA

Faheez Mohamed, Kaiumarz Sethna, Dominique Elias, Paul H. Sugarbaker

The Washington Cancer Institute, Washington Hospital Center, Washington, DC; and the Department of Surgical Oncology, Institut Gustave Roussy, Villejuif, France

A 50-year-old man presented with diffuse abdominal discomfort and increasing distension. He had undergone umbilical herniorrhaphy 18 months previously and was found to have ascites. Subsequent laparoscopy revealed multiple cystic lesions that were biopsied, and histopathologic diagnosis of peritoneal cystic mesothelioma was confirmed by immunocytochemistry. Computed tomography scan of the abdomen showed massive accumulation of multiloculated ascitic fluid with compartmentalization of the small bowel (Fig 1Go). At surgical exploration, there was a conglomeration of cystic structures contained within the greater omentum ranging in size from 1 mm to 10 cm in diameter, filling the abdomen and pelvis. The greater omentum was most extensively involved (Fig 2Go). The parietal peritoneal surfaces contained small nodules that could be debrided away. The surface of the liver, gallbladder, and spleen were free of tumor. There was no evidence of soft tissue invasion.



View larger version (90K):
[in this window]
[in a new window]
 
Fig. 1. Computed tomography scan of the abdomen, showing the pathognomic apearance of cystic peritoneal mesothelioma. A conglomerate of multiple thin-walled cysts occupies the abdomino-pelvic space.

 


View larger version (110K):
[in this window]
[in a new window]
 
Fig. 2. Intraoperative photograph, showing characteristic thin-walled cysts in the pelvis.

 
A greater and lesser omentectomy, partial stripping of the right hemidiaphragm (to remove the tumor from the right retrohepatic space), pelvic peritonectomy, and left colectomy with primary anastomosis were performed with heated intraoperative intraperitoneal chemotherapy (doxorubicin and cis-platinum). A tumor specimen weighing approximately 18 lb was resected. Histopathologic analysis revealed variably sized coalescent cysts with fibrocollagenous walls lined by cuboidal mesothelial cells with mild atypia. No solid or tubulopapillary components were noted (Fig 3Go).



View larger version (142K):
[in this window]
[in a new window]
 
Fig. 3. Histology showing variably sized coalescent cysts with fibro-collagenous walls and flattened cuboidal mesothelial cells.

 
Immunohistochemistry tests confirmed that the cyst lining cells were positive for vimentin, cytokeratins (monoclonal antibodies to lowmolecular-weight keratins CAM 5.2 and AE1/AE3) and stained strongly for calretinin and cytokeratin 5/6, consistent with a mesothelial origin. The primary differential diagnosis was lymphangioma; however, all endothelial markers were negative (factor 8, CD31, CD34).

The patient required a second surgery at 24 hours postoperatively for a bile leak from the liver edge, which was sutured. The patient remains free of disease after 5 years and has no sign of recurrence clinically or on recent CT scan.

Peritoneal cystic mesothelioma is a rare tumor for which pathophysiology remains equivocal and controversial. It occurs predominantly in young to middle-aged women; only 17% of these tumors occur in men. It is frequently associated with a positive history of previous abdominal surgery, pelvic inflammatory disease, and leiomyoma of the uterus. No racial, genetic, or environmental (such as asbestos exposure) influence has been reported. It is difficult to make a firm preoperative diagnosis of cystic mesothelioma. Computed tomography scan typically shows a well-defined, noncalcified, multiloculated mass. The cyst contents have a Hounsfield density similar to that of water. The cyst walls are thin and enhance with contrast.

Weiss and Tavassoli1 reviewed 37 patient cases from the Armed Forces Institute of Pathology, Washington, DC, accumulated between the years 1972 and 1987. Although the cytopathology was bland and the inflammatory changes marked, they suggested that this entity be regarded as a neoplastic rather than a reactive process. They noted recurrences and occasional transition to conventional malignant mesothelioma.1 Ross et al2 reported 12 of 25 patients who developed a recurrence. Sometimes the lesions showed changes suggestive of malignant mesothelioma. Lack of follow-up prevented a prognostic assessment.2 Immunohistochemical studies allow the separation of reactive and neoplastic lesions.3

Cystic mesotheliomas are thought to be benign because they do not metastasize; however, they have a high propensity for local recurrence.4,5 Recurrence may occur in 27% to 75% of the patients within 3 months to 22 years of the initial resection.6,7 The concept of peritoneal stripping for these patients was introduced by Datta and Paty.8 Combined modality treatment with cytoreductive surgery plus heated intraoperative intraperitoneal chemotherapy may minimize the high risk of recurrence. The use of heated intraoperative intraperitoneal chemotherapy (procedure is in trials) may eradicate free tumor cells that implant and then progress over an extended time. This strategy has been successful in the treatment of pseudomyxoma peritonei9 and may lead to prolonged disease-free survival for patients with cystic mesothelioma.

REFERENCES

1. Weiss SW, Tavassoli FA: Multicystic mesothelioma: An analysis of pathological findings and biologic behavior in 37 cases. Am J Surg Pathol 12:737–746, 1988[Medline]

2. Ross MJ, Welch WR, Scully RE: Multilocular peritoneal inclusion cysts (so-called cystic mesotheliomas). Cancer 64:1336–1346, 1989[CrossRef][Medline]

3. Cusatelli P, Altavilla G, Marchetti M: Benign cystic mesothelioma of peritoneum: A case report. Eur J Gynaecol Oncol 18:124–126, 1997[Medline]

4. O’Neill JD, Ros PR, Storm BL, et al: Cystic mesothelioma of the peritoneum. Radiology 170:333–337, 1989[Abstract/Free Full Text]

5. Schneider JA, Zelnick EJ: Benign cystic peritoneal mesothelioma. J Clin Ultrasound 13:190–192, 1985[Medline]

6. Katsube Y, Mukai K, Silverberg S: Cystic mesothelioma of the peritoneum: A report of 5 cases and review of literature. Cancer 50:1615–1622, 1982[CrossRef][Medline]

7. Miles JM, Hart WR, McMahon JT: Cystic mesothelioma of the peritoneum—Report of a case with multiple recurrences and review of the literature. Cleve Clin Q 53:109–114, 1986[Medline]

8. Datta RV, Paty PB: Cystic mesothelioma of the peritoneum. Eur J Surg Oncol 23:461–462, 1997[CrossRef][Medline]

9. Sugarbaker PH, Ronnett BM, Archer A, et al: Pseudomyxoma peritonei syndrome. Adv Surg 30:233–280, 1996[Medline]





This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohamed, F.
Right arrow Articles by Sugarbaker, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohamed, F.
Right arrow Articles by Sugarbaker, P. H.

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online